GSK’s asthma biologic hits quality of life goal
admin 7th March 2017 Uncategorised 0GlaxoSmithKline has presented new data showing that its asthma drug Nucala “significantly improves” quality of life and lung function in patients with a severe, eosinophilic form of the condition.
More: GSK’s asthma biologic hits quality of life goal
Source: News